OB/GYN Clinical Alert – April 1, 2010
April 1, 2010
View Issues
-
Ulipristal Acetate Extends the Emergency Contraception Window
In this open-label study, women ages 18 years or older with regular cycles who presented for emergency contraception 48-120 hours after unprotected intercourse at 45 Planned Parenthood clinics throughout the United States were treated with a single oral dose of 30 mg ulipristal acetate. -
Delivery of a Second Twin
In a recent issue of OB/GYN Clinical Alert (see the November 2009 issue), a special feature was devoted to the contemporary antepartum management of twin pregnancies. -
Decreasing Surgical Site Infections
Darouiche and colleagues performed a u.s. multicenter randomized clinical trial of 849 patients undergoing clean-contaminated surgical procedures. -
Pessary Management of Incontinence
In this multicenter trial, patients with documented stress urinary incontinence (SUI) with a pelvic organ prolapse quantification (POPQ) score < 2 were randomized to groups that received an incontinence pessary or an incontinence pessary along with behavioral therapy. -
Laparoscopy vs Laparotomy for Endometrial Cancer Staging: The Lap2 Report
Endometrial cancer is the most common gynecologic malignancy and most often presents with corpus-limited disease. -
Pharmacology Watch: Thiazolidinediones and Risk of Heart Failure
In this issue: FDA is reviewing safety of TZDs; SSRI use with tamoxifen; Metformin smells like fish; FDA Actions. -
Clinical Briefs in Primary Care supplement